CuraYou's ProWave Deep Healing Pad™ delivers red and infrared light therapy for thyroid health in a device designed for daily home use. The thyroid gland sits just below the skin of the neck, making it one of the most accessible targets for light-based treatment, and the clinical research behind light therapy for thyroid health now spans more than 15 years across multiple independent research teams. A 2026 systematic review pooling six clinical studies found consistent reductions in thyroid antibodies, improved hormone measures, and lower medication needs in patients with Hashimoto's thyroiditis. But research only translates into benefit when it is built into something a person can use at home, consistently, at the right parameters. This article covers exactly how the Cura ProWave Deep Healing Pad™ does that: which wavelengths it uses, why it uses LEDs instead of the clinical lasers in the original trials, how much power it delivers, and what treatment routine CuraYou recommends.
Part of our complete guide to Red and Infrared Light Therapy for Thyroid Health.
Key Takeaways
- The wavelengths match the research. The Cura ProWave Deep Healing Pad™ delivers 850 nm near-infrared light from 240 light chips and 660 nm red light from 120 light chips, 360 in total, at 200 mW/cm² across an 18 × 8 inch flexible pad. Every thyroid clinical trial used near-infrared wavelengths in the 820–850 nm range, and the foundational cell study by Wong-Riley et al. (2005) established that 830 nm is among the most effective wavelengths for activating the mitochondrial enzyme that drives the entire cellular response.
- LED evidence supports the approach. Light therapy works through wavelength and dose, not the type of device. Heiskanen and Hamblin (2018) of Massachusetts General Hospital and Harvard concluded that photobiomodulation does not depend on lasers or coherence, and that LED therapy appears as effective as laser therapy for surface-tissue applications at matched wavelength and dose. The thyroid sits directly beneath the skin, making it a surface-accessible target.
- The protocol supports consistent daily use. CuraYou recommends daily 20-minute sessions targeting the front of the neck, in line with the clinical evidence showing that accumulated, consistent treatment produced the strongest and longest-lasting results. Three modes (red only, infrared only, or combined) let you target the therapy to your situation. Most clinical trials showed measurable improvements within the first 4–6 weeks of treatment.
What the Research Requires
How Red and Infrared Light Therapy Help Thyroid Health
Red and infrared light therapy (photobiomodulation) targets the autoimmune damage that drives Hashimoto's thyroiditis at multiple biological levels simultaneously. Near-infrared light in the 820–850 nm range passes through the thin skin of the neck and reaches the thyroid gland, where it is absorbed by cytochrome c oxidase, a key enzyme in the cell's energy-producing machinery (Wong-Riley et al., 2005). That absorption triggers a cascade of cellular responses: increased energy production in thyroid cells weakened by chronic autoimmune attack, reduced inflammatory signaling, lower oxidative stress, improved blood flow to the gland, and a shift in the immune response away from tissue destruction and toward tolerance (Hamblin, 2017). The 2026 systematic review by Berisha-Muharremi and Humolli, the first to formally evaluate light therapy for Hashimoto's, pooled six clinical studies and found consistent improvements across these pathways. A randomized, placebo-controlled trial (Höfling et al., 2012) found treated patients needed less than half the thyroid medication of the placebo group, with lower antibodies and improved gland appearance on ultrasound. A six-year follow-up (Höfling et al., 2018) confirmed the benefit held with no safety concerns.
Wavelength, Dose, and Protocol
For any device to deliver these benefits, the research points to specific requirements. All six clinical studies reviewed in the 2026 systematic review used near-infrared wavelengths in the 820–850 nm range. This is not arbitrary: Wong-Riley and colleagues (2005) established that 830 nm corresponds to the absorption peak of oxidized cytochrome c oxidase, the mitochondrial enzyme that drives the cellular response. Red light at 660 nm targets a second absorption peak of the same enzyme, and the combination of both wavelengths has been shown to produce complementary effects on cellular energy and inflammation (Hamblin, 2017).
Light therapy follows a biphasic dose response: too little produces no meaningful effect, while too much can actually diminish the response (Huang et al., 2009). The thyroid trials used protocols of 6 to 10 sessions over one to five weeks, applied to several points on both sides of the gland, with power outputs ranging from 50 to 200 mW. The pilot study (Höfling et al., 2010) showed measurable medication reduction within months after treatment. The placebo-controlled trial (Höfling et al., 2012) confirmed the pattern, and a sham-controlled trial (Tunç et al., 2024) found improved oxidative stress markers and quality of life at three months. The evidence is consistent: improvements typically become measurable within the first 4–6 weeks of treatment and build with continued use.
The therapy has a strong safety profile. The six-year follow-up (Höfling et al., 2018) found no increase in thyroid nodules and no malignant findings. A human LED safety study (Lee et al., 2021) found no change in thyroid function or ultrasound after 16 weeks of daily LED use over the neck. A randomized, sham-controlled LED trial (Kim et al., 2022) supported the safety of near-infrared light applied to the neck. No study to date has reported adverse effects at treatment-level doses. What determines whether someone sees results is delivering the right wavelengths at sufficient power, consistently, parameters that vary widely across consumer devices.
Most of my Hashimoto's patients are frustrated because their labs look normal but they still feel exhausted. The levothyroxine is doing its job on the hormone side. But the autoimmune process, the inflammation, the oxidative damage to the gland: those keep running underneath. That is exactly the gap this research is trying to close. The consistency of the results across independent teams is what makes it worth watching.— Dr. William Carter, MD
Why the Cura ProWave Deep Healing Pad™ Uses LEDs Instead of Lasers
All six clinical trials in the 2026 systematic review used professional lasers applied in a clinical setting. So why does the Cura ProWave Deep Healing Pad™ use LEDs?
The Biology Does Not Require a Laser
The cellular response to light depends on wavelength and dose, not the delivery device. A photon at 850 nm triggers the same response in cytochrome c oxidase whether it originates from a laser or an LED. Wong-Riley and colleagues (2005) demonstrated this directly: LEDs at 670 and 830 nm fully restored enzyme activity and ATP production in metabolically compromised neurons, and the action spectrum of effective wavelengths corresponded to the absorption spectrum of cytochrome c oxidase regardless of whether the light was coherent. The most thorough review of the question, by Heiskanen and Hamblin (2018) of Massachusetts General Hospital and Harvard, concluded that photobiomodulation does not depend on lasers or coherence, and that LED therapy appears as effective as laser therapy for surface-tissue applications at matched wavelength and dose.
The thyroid gland sits directly beneath the thin skin of the anterior neck. Unlike deep spinal tissue that requires light to penetrate through multiple layers, the thyroid is a surface-accessible target. This makes it well suited for LED-based delivery, where the slight advantage lasers hold in deep-tissue penetration is not a limiting factor.
LED Covers the Entire Thyroid Region at Once
The thyroid has two lobes connected by a central bridge, spanning roughly 4–6 cm across the front of the neck. The clinical laser protocols applied light point by point across both lobes, requiring a trained practitioner to manually reposition the probe at each treatment site. An LED array built into a flexible pad covers the whole gland and surrounding tissue in a single placement. The Cura ProWave Deep Healing Pad™'s 120-LED array across an 18 × 8 inch pad delivers uniform coverage without manual repositioning, so no part of the gland is missed and both lobes are treated simultaneously.
LED Makes Daily Home Use Possible
The strongest clinical results came from treatment courses of multiple sessions per week, and the six-year follow-up (Höfling et al., 2018) noted that periodic retreatment may optimize long-term outcomes. Clinical laser sessions require a clinic visit each time, administered by a trained professional, which makes the kind of sustained, regular treatment the evidence rewards impractical for most people. A home LED device lets you treat daily over weeks and months, which is the consistency the research ties to the best outcomes.
Safe for Unsupervised Use
The lasers used in the thyroid trials are Class 3B medical devices that require trained operators and protective eyewear. LED devices operate at power levels that do not carry those risks. The Cura ProWave Deep Healing Pad™ is FDA Registered and ISO Certified, with 0 V/m EMF output, and the LED safety evidence specifically tested daily at-home use over the neck and found no adverse effects on thyroid function, structure, or safety markers.
How the Cura ProWave Deep Healing Pad™ Delivers Light Therapy
Wavelengths
The Cura ProWave Deep Healing Pad™ is built around 120 medical-grade triple-chip LEDs: 240 light chips near-infrared at 850 nm and 120 light chips red at 660 nm. Both fall within the ranges documented in the thyroid research. The 850 nm near-infrared sits in the wavelength range used across all six clinical trials in the 2026 systematic review, and corresponds to the absorption peak of oxidized cytochrome c oxidase that Wong-Riley et al. (2005) identified as most effective for restoring cellular energy. The 660 nm red light hits a second absorption peak of the same enzyme and adds anti-inflammatory and surface-tissue effects that complement the deeper-reaching infrared. Using both wavelengths together means the device acts on the thyroid through multiple absorption pathways simultaneously.
Power Density: Why It Matters
The Cura ProWave Deep Healing Pad™ delivers 200 mW/cm², among the highest power density for a home-use LED device. Power density determines how much light energy reaches the tissue per unit area. This matters because the thyroid research consistently shows that adequate dosing produces results and underdosing does not. The placebo-controlled trial (Höfling et al., 2012) used carefully calibrated doses that produced the medication-halving result; the placebo group, receiving negligible light energy from the same device, showed no improvement.
Even though the thyroid is close to the surface, some light energy is absorbed by skin and connective tissue before reaching the gland. Higher surface power means more energy arrives at the thyroid cells where the work happens. At 200 mW/cm² across a treatment session, the Cura ProWave Deep Healing Pad™ delivers substantially more energy to the target tissue than lower-powered devices, staying within the effective dose window rather than the underpowered range the research links to null results.
Full Thyroid Coverage
The pad measures 18 × 8 inches, large enough to wrap around the entire front and sides of the neck, and its flexible neoprene material conforms to the contours so the LEDs maintain close contact across both thyroid lobes and surrounding tissue. The strap system was designed to be easy to secure without help, which matters especially for older users or anyone with limited hand dexterity. Where the clinical laser protocols required a practitioner to move a probe point by point across the gland, the Cura ProWave Deep Healing Pad™ treats the full thyroid area at once with uniform delivery.
Three Treatment Modes
The device runs in three modes: red only (660 nm), infrared only (850 nm), and combined. The thyroid clinical trials used near-infrared exclusively, so infrared mode directly mirrors the research parameters. Combined mode adds the surface-level anti-inflammatory effects of 660 nm red light on top of the deeper-reaching near-infrared, which may be beneficial for reducing inflammation in the tissue surrounding the gland. Red-only mode offers a lower-penetration option for surface tissue. The ability to run each wavelength separately or together means treatment can be tailored to the situation and adjusted over time.
Pre-Set Modes and Guided Routine
The Cura ProWave Deep Healing Pad™ includes pre-set modes with parameters chosen to fall within the therapeutic dose window, removing the guesswork that undermines generic light therapy devices. This matters specifically for thyroid applications because of the biphasic dose response documented by Huang et al. (2009): both too little and too much light can reduce the therapeutic effect, so the pre-sets keep treatment within the effective range. The device comes with a cellular restoration protocol and progress-tracking tools to help build a daily habit, because the thyroid research consistently ties the strongest results to sustained, accumulated treatment over weeks and months. A device used sporadically will not reproduce what the clinical trials achieved.
CuraYou's Recommended Routine for Thyroid Health
Based on the research parameters and the thyroid's accessibility beneath the anterior neck, CuraYou recommends daily 20-minute sessions in the infrared or combined mode, with the pad positioned across the front of the neck so both thyroid lobes are fully covered. Infrared mode mirrors the clinical trial protocols most closely. Combined mode adds red-light anti-inflammatory effects for broader coverage. CuraYou's human support team can help tailor the routine, since someone focused on antibody reduction may approach treatment differently than someone primarily targeting fatigue and quality of life, as studied in the Tunç et al. (2026) trial.
Medical-Grade Quality and Real Support
The Cura ProWave Deep Healing Pad™ is FDA Registered and ISO Certified, with precise wavelengths within the documented therapeutic ranges. Its 0 V/m EMF rating means no electromagnetic field exposure during treatment, consistent with the safety profile documented across thyroid studies. The LEDs are rated for 50,000 hours, maintaining their output across years of daily use. It can be purchased with an HSA or FSA card and is backed by up to a 3-year warranty. CuraYou provides real human support to help tailor your routine and answer questions. We are not a large brand hiding behind chatbots: hundreds of verified customer reviews document the results people report, and our team is available to help you optimize your therapy.
Conclusion
The Cura ProWave Deep Healing Pad™ takes the research behind red and infrared light therapy for thyroid health and builds it into a device made for daily home use. Its 850 nm near-infrared and 660 nm red LEDs deliver the wavelengths studied across more than 15 years of clinical research, including a randomized placebo-controlled trial, a six-year safety follow-up, and a 2026 systematic review of six studies. Its 200 mW/cm² power density is built to deliver adequate dosing to the thyroid gland, and its 120-LED, 18 × 8 inch flexible pad treats the entire thyroid region at once rather than one point at a time. Clinical trials show measurable improvements in thyroid antibodies, medication needs, oxidative stress, and quality of life within the first 4–6 weeks of consistent treatment, with benefits building over longer courses and, in the longest study, confirmed safe and effective at six years. That timeline fits well within CuraYou's 60-day risk-free return guarantee, which gives you time to experience the difference for yourself, or receive a full refund if the therapy is not right for you.
